Skip to main content
OpenTrials
Completed

NCT Number: NCT05447897

Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers

Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Health Behavior

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massacusetts General Hospital

Boston, Massachusetts, 02114, United States

About this study

Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke.

Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

FQHC implementation team including staff in the intervention FQHCs and their lung screening partners

Exclusion criteria

FQHC staff or partners who leave the organization before end of study

Treatment and study plan

Qualitative Group Interviews

Other

One time interview, 60-90 minutes

Stakeholder advisory group

Other

The team will meet with the stakeholder advisory group four times for 1-2 hours each

Primary outcomes

  1. Feasibility of Intervention Measure

    Time frame: End of study, up to 16 weeks

    Feasibility of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Secondary outcomes

  1. Acceptability of Intervention Measure

    Time frame: End of study, up to 16 weeks

    Acceptability of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

  2. Intervention Appropriateness Measure

    Time frame: End of study, up to 16 weeks

    Intervention appropriateness measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

A Systematic Approach to Designing an Implementation Strategy to Increase Lung Cancer Screening and Smoking Cessation Treatment Among Federally Qualified Community Health Center Patients Who Smoke

Acronym: SAILS-FQHC

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jul 7, 2022
Registry last updated
Apr 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.